Proveca is a specialist pharmaceutical company focused on medicines for children. It's lead product, Sialanar™ is a licensed drug (PUMA) for chronic pathological drooling based on a new formulation of a well-known medicine and is marketed across Europe.
Why we like the business
Proveca has a very strong management team. The two founders have extensive experience in the development and licensing of medicines for children - having secured the very first Paediatric Use Market Authorisation (PUMA) in Europe. Also, the commercial team have proven success in pharmaceutical sales and marketing at c-level with global pharma.